Direct Latest news about the coronavirus
The pharmaceutical company MSD, known as
Merck
in the United States and Canada, has announced that its experimental drug against Covid-19,
molnupinavir
, reduces by 50% the chances of hospitalization and death in patients at risk of development.
Become Premium from € 1 the first month
Take advantage of this limited-time offer and access all web content
I love you
Are you already Premium?
Log in
Cancel whenever you want